Respira Technologies (West Hollywood, Calif.) announced the launch of a pharmaceutical-focused commercial development program for its RespiRx drug-delivery device platform. RespiRx is a portable, handheld vibrating mesh nebulizer designed for local and systemic treatment and can operate in any position held…
Merck, IAVI Work to Develop COVID-19 Vaccine
Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technology used as the basis for Merck’s Ervebo Ebola Zaire virus…
Phlow Lands $354M Government Contract for COVID-19 Medications
Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response. This Covid-19 medications will be a helping aid to succeed against this terrible…
Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year
Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. Janssen and the virology lab led by Dr. Dan Barouch at BIDMC have…
How is coronavirus vaccine development going in the U.S.?
Researchers in Pittsburgh and Boston are moving forward with research into two separate coronavirus vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine researchers is detailed in a paper published recently…
6 ways to prepare your medical practice for coronavirus
Many physician practices throughout the U.S. are starting to see the impact of the coronavirus(COVID-19). As the highly contagious virus is only likely to spread in the weeks ahead, now is the time for leaders to prepare for how they will…
Nanotechnology Treatment Shows Promise Against Multiple Sclerosis
A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by the University of California, Irvine researchers.
Genetic Marker Identified for Crohn’s Disease Drug Response
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn’s disease has identified a genetic marker that could individualize drug treatment. UK-Wide Collaboration and Study Findings A UK-wide collaboration led…
Stanford University Researchers Synthesize Scorpion Venom to Combat Drug-Resistant Tuberculosis Bacteria
Researchers at Stanford University and in Mexico have found that scorpion venom contains two color-changing compounds that could help fight bacterial infections. The potential pharmacological treasures awaiting discovery in the toxins of scorpions, snakes, snails and other poisonous creatures could lead to countless medical advancements.
Enhanced Human Blood-Brain Barrier Chip Performs in Vivo-Like Drug and Antibody Transport
This illustration shows how In the Blood-Brain-Barrier (BBB), thin endothelial capillaries (red) are wrapped by supporting pericytes (green) and astrocytes (yellow), enabling them to generate a tight barrier with highly selective transport functions for molecules entering the brain fluid from the…